Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 5 of 5 entries
Sorted by: Best Match Show Resources per page
Pulmonary embolism in a healthy woman using the oral contraceptives containing desogestrel.

Obstetrics & gynecology science

Park MJ, Jeon GH.
PMID: 28344968
Obstet Gynecol Sci. 2017 Mar;60(2):232-235. doi: 10.5468/ogs.2017.60.2.232. Epub 2017 Mar 16.

Venous thromboembolism is well known as one of the rare but serious adverse effects of combined oral contraceptives (COCs). The COCs with third and fourth generation progestogens were found to have higher risk of venous thrombosis than those with...

Cite
Park MJ, Jeon GH. Pulmonary embolism in a healthy woman using the oral contraceptives containing desogestrel. Obstet Gynecol Sci. 2017;60(2):232-235doi: 10.5468/ogs.2017.60.2.232.
Park, M. J., & Jeon, G. H. (2017). Pulmonary embolism in a healthy woman using the oral contraceptives containing desogestrel. Obstetrics & gynecology science, 60(2), 232-235. https://doi.org/10.5468/ogs.2017.60.2.232
Park, Min-Jeong, and Jeon, Gyun-Ho. "Pulmonary embolism in a healthy woman using the oral contraceptives containing desogestrel." Obstetrics & gynecology science vol. 60,2 (2017): 232-235. doi: https://doi.org/10.5468/ogs.2017.60.2.232
Park MJ, Jeon GH. Pulmonary embolism in a healthy woman using the oral contraceptives containing desogestrel. Obstet Gynecol Sci. 2017 Mar;60(2):232-235. doi: 10.5468/ogs.2017.60.2.232. Epub 2017 Mar 16. PMID: 28344968; PMCID: PMC5364109.
Copy Download .nbib Format: NLM
Use of Combined Oral Contraceptives in Perimenopausal Women.

Chonnam medical journal

Cho MK.
PMID: 30288370
Chonnam Med J. 2018 Sep;54(3):153-158. doi: 10.4068/cmj.2018.54.3.153. Epub 2018 Sep 27.

While perimenopausal women have low fecundity, they are still capable of becoming pregnant and the majority of pregnancies occurring during perimenopause are unintended pregnancies. Therefore, even during perimenopause, contraception must be used if unintended pregnancies are to be avoided....

Cite
Cho MK. Use of Combined Oral Contraceptives in Perimenopausal Women. Chonnam Med J. 2018;54(3):153-158doi: 10.4068/cmj.2018.54.3.153.
Cho, M. K. (2018). Use of Combined Oral Contraceptives in Perimenopausal Women. Chonnam medical journal, 54(3), 153-158. https://doi.org/10.4068/cmj.2018.54.3.153
Cho, Moon Kyoung. "Use of Combined Oral Contraceptives in Perimenopausal Women." Chonnam medical journal vol. 54,3 (2018): 153-158. doi: https://doi.org/10.4068/cmj.2018.54.3.153
Cho MK. Use of Combined Oral Contraceptives in Perimenopausal Women. Chonnam Med J. 2018 Sep;54(3):153-158. doi: 10.4068/cmj.2018.54.3.153. Epub 2018 Sep 27. PMID: 30288370; PMCID: PMC6165915.
Copy Download .nbib Format: NLM
Efficacy and safety of a 24-day regimen of drospirenone-containing combined oral contraceptive in Korean women.

Obstetrics & gynecology science

Kim N, Yoo HN, Hyun HS, Lee DY, Yoon BK, Choi DS.
PMID: 26430665
Obstet Gynecol Sci. 2015 Sep;58(5):397-400. doi: 10.5468/ogs.2015.58.5.397. Epub 2015 Sep 22.

This study assesses the efficacy and safety of a 24-day regimen of drospirenone-containing combined oral contraceptive, and demonstrates that it is an effective and safe option for contraception, releasing symptom of premenstrual dysphoric disorder and acne in Korean women.

Cite
Kim N, Yoo HN, Hyun HS, et al. Efficacy and safety of a 24-day regimen of drospirenone-containing combined oral contraceptive in Korean women. Obstet Gynecol Sci. 2015;58(5):397-400doi: 10.5468/ogs.2015.58.5.397.
Kim, N., Yoo, H. N., Hyun, H. S., Lee, D. Y., Yoon, B. K., & Choi, D. S. (2015). Efficacy and safety of a 24-day regimen of drospirenone-containing combined oral contraceptive in Korean women. Obstetrics & gynecology science, 58(5), 397-400. https://doi.org/10.5468/ogs.2015.58.5.397
Kim, Nayoung, et al. "Efficacy and safety of a 24-day regimen of drospirenone-containing combined oral contraceptive in Korean women." Obstetrics & gynecology science vol. 58,5 (2015): 397-400. doi: https://doi.org/10.5468/ogs.2015.58.5.397
Kim N, Yoo HN, Hyun HS, Lee DY, Yoon BK, Choi DS. Efficacy and safety of a 24-day regimen of drospirenone-containing combined oral contraceptive in Korean women. Obstet Gynecol Sci. 2015 Sep;58(5):397-400. doi: 10.5468/ogs.2015.58.5.397. Epub 2015 Sep 22. PMID: 26430665; PMCID: PMC4588845.
Copy Download .nbib Format: NLM
Venous thromboembolism associated with combined oral contraceptive use: a single-institution experience.

Obstetrics & gynecology science

Jang YS, Lee ES, Kim YK.
PMID: 33794564
Obstet Gynecol Sci. 2021 Jul;64(4):337-344. doi: 10.5468/ogs.20374. Epub 2021 Apr 01.

OBJECTIVE: Combined oral contraceptives (COCs) are used for various reasons. However, venous thromboembolism (VTE), a significant side effect, can be fatal. This study reports the first case series in Korea involving patients with COC-associated VTE registered at a university...

Cite
Jang YS, Lee ES, Kim YK. Venous thromboembolism associated with combined oral contraceptive use: a single-institution experience. Obstet Gynecol Sci. 2021;64(4):337-344doi: 10.5468/ogs.20374.
Jang, Y. S., Lee, E. S., & Kim, Y. K. (2021). Venous thromboembolism associated with combined oral contraceptive use: a single-institution experience. Obstetrics & gynecology science, 64(4), 337-344. https://doi.org/10.5468/ogs.20374
Jang, Yong-Su, et al. "Venous thromboembolism associated with combined oral contraceptive use: a single-institution experience." Obstetrics & gynecology science vol. 64,4 (2021): 337-344. doi: https://doi.org/10.5468/ogs.20374
Jang YS, Lee ES, Kim YK. Venous thromboembolism associated with combined oral contraceptive use: a single-institution experience. Obstet Gynecol Sci. 2021 Jul;64(4):337-344. doi: 10.5468/ogs.20374. Epub 2021 Apr 01. PMID: 33794564; PMCID: PMC8290149.
Copy Download .nbib Format: NLM
Pretreatment of normal responders in fresh .

Clinical and experimental reproductive medicine

Pereira N, Petrini AC, Zhou ZN, Lekovich JP, Kligman I, Rosenwaks Z.
PMID: 28090462
Clin Exp Reprod Med. 2016 Dec;43(4):228-232. doi: 10.5653/cerm.2016.43.4.228. Epub 2016 Dec 26.

OBJECTIVE: The aim of this study was to investigate the impact of pretreatment with transdermal estradiol (EMETHODS: A retrospective cohort study was performed of normal responders undergoing fresh IVF-ET cycles who received pretreatment with transdermal ERESULTS: A total of...

Cite
Pereira N, Petrini AC, Zhou ZN, et al. Pretreatment of normal responders in fresh . Clin Exp Reprod Med. 2016;43(4):228-232doi: 10.5653/cerm.2016.43.4.228.
Pereira, N., Petrini, A. C., Zhou, Z. N., Lekovich, J. P., Kligman, I., & Rosenwaks, Z. (2016). Pretreatment of normal responders in fresh . Clinical and experimental reproductive medicine, 43(4), 228-232. https://doi.org/10.5653/cerm.2016.43.4.228
Pereira, Nigel, et al. "Pretreatment of normal responders in fresh ." Clinical and experimental reproductive medicine vol. 43,4 (2016): 228-232. doi: https://doi.org/10.5653/cerm.2016.43.4.228
Pereira N, Petrini AC, Zhou ZN, Lekovich JP, Kligman I, Rosenwaks Z. Pretreatment of normal responders in fresh . Clin Exp Reprod Med. 2016 Dec;43(4):228-232. doi: 10.5653/cerm.2016.43.4.228. Epub 2016 Dec 26. PMID: 28090462; PMCID: PMC5234290.
Copy Download .nbib Format: NLM
Showing 1 to 5 of 5 entries